PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccinesINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESIF8.52024-03-011PRE
Novel personalized cancer vaccine platform based on Bacillus Calmette-GuerinJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-07-1517OAAI
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platformMOLECULAR THERAPY-ONCOLYTICSIF02021-03-0136OAAI
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer ImmunotherapyCANCER RESEARCHIF16.62020-06-1545PREAI
Artificially cloaked viral nanovaccine for cancer immunotherapyNATURE COMMUNICATIONSIF15.72019-12-1796OAAI
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped VirusesMOLECULAR THERAPYIF122018-09-0140OAAI
Identification of specific residues in avian influenza A virus NS1 that enhance viral replication and pathogenicity in mammalian systemsJOURNAL OF GENERAL VIROLOGYIF4.32016-09-0118OA
Nuclear Translocation of Crk Adaptor Proteins by the Influenza A Virus NS1 Protein甲型流感病毒NS1蛋白对Crk衔接蛋白的核易位VIRUSES-BASELIF3.52016-04-157OAAI